Synthetic DNA technology was used to engineer a novel eCD4-Ig anti-HIV agent while enhancing its potency ‘in vivo’ which was done by researchers at The Wistar Institute. Such technology has provided a ...
eight months ago, produces Covid-19 technology to identify new variants, but its expertise in testing DNA and analyzing data is where its growth lays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback